Flowserve supports Pfizer in US production of COVID-19 vaccines 23 March 2021
Pump manufacturer Flowserve Corp is providing pumps, valves and seals to Pfizer to support production of its COVID-19 vaccine.
During the engineering runs of vaccine production, Pfizer needed immediate support to replace a mechanical mixer seal on its US COVID-19 vaccine production line (the exact type was not specified). Flowserve understood the urgency of the situation and the Flowserve Kalamazoo, Michigan team expedited the rebuild of this critical equipment. Pfizer has been a Flowserve lifecycle advantage customer since 1997, said Scott Rowe, Flowserve president and chief executive officer, referring to one of the company’s equipment service agreements.
Second, through channel partner Corrosion Fluid Products, Flowserve is providing Pfizer with a cryogenic valve application to support its expanded production capabilities of the COVID-19 vaccine. The Flowserve Cookeville, Tennessee facility will supply Pfizer with more than 200 Worcester cryogenic ball valves that can handle the rigorous temperature requirements needed in supporting the mass production of the COVID-19 vaccine.
Third, Flowserve’s Chesapeake, Virginia and Itzehoe, Germany pump manufacturing facilities are providing pumps to Pfizer for both North American and European vaccine production.
This material is protected by MA Business copyright
See Terms and Conditions.
One-off usage is permitted but bulk copying is not.
For multiple copies
contact the sales team.